The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Volume reached 2,803 shares, with price reaching a high of $8.65 and a low of $8.53. Recently, Yahoo Finance discussed the stock, revealing that Zynex Ranked in Top 50 Public Companies in Colorado.
Zynex Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $8.65 and fluctuated between $8.65 as its day high and $8.37 as its day low. The current market capitalization of Zynex Inc. is $293.75M. A total of 0.27 million shares were traded on the day, compared to an average of 408.67K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ZYXI has seen 4 BUY and 9 SELL insider trades, representing the acquisition of 35,000 and the disposition of 5,471 shares. Over the last 12 months, there were 18 BUYs and 35 SELLs from insiders. Insiders purchased 116,116 shares during that period but sold 202,408.
In the most recent transaction, Sandgaard Thomas sold 177,320 shares of ZYXI for 15.17 per share on Aug 06. After the transaction, the President, CEO and Chairman now owns 13,617,420 company shares.
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ZYXI in the last 3 months, the mean price target is $16.63 with high estimates of $28.50 and low estimates of $7.00. In terms of 52-week highs and lows, ZYXI has a high of $14.09 and a low of $4.97.
As of this writing, ZYXI has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.12 per share and a lower estimate of $0.11. The company reported an EPS of $0.08 in the last quarter, which was 14.29% higher than expectations of $0.07.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZYXI is Buy with a score of 4.50. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.